SBI ALApharma Canada Inc. is currently performing a pivotal Phase III randomized controlled clinical trial. This trial will evaluate the safety and efficacy of the imaging agent PD G 506 A (5-Aminolevulinic Acid) during breast conserving surgery, for real-time intraoperative fluorescence visualization of cancer.
View Top Employees from SBI ALApharma Canada Inc.Website | https://www.sbi-alapharmacanada.ca |
Employees | 14 (6 on RocketReach) |
Founded | 2019 |
Address | 123 Edward St, Suite 305, Toronto, Ontario M5G 1E2, CA |
Industry | Biotechnology Research |
Looking for a particular SBI ALApharma Canada Inc. employee's phone or email?
6 people are employed at SBI ALApharma Canada Inc..
SBI ALApharma Canada Inc. is based in Toronto, Ontario.